Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients With Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis

Oncologist - United States
doi 10.1634/theoncologist.2019-0736
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Analysis of Clinical Outcome of Patients With Poorly Differentiated Thyroid Carcinoma

ISRN Endocrinology
2011English

Clinicopathological Study of Poorly Differentiated Adenocarcinoma and Mucinous Carcinoma of the Colon

The KITAKANTO Medical Journal
1993English

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

A Clinicopathological Studies on 25 Patients With Poorly Differentiated Adenocarcinoma of the Colon and Rectum.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1992English

The Preoperative Lymphocyte to Monocyte Ratio Predicts Clinical Outcome in Patients With Stage III Colon Cancer

British Journal of Cancer
Cancer ResearchOncology
2013English

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients With Resected Colon Cancer: A TOSCA Study Subanalysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Villin Expression Is Frequently Lost in Poorly Differentiated Colon Cancer

American Journal of Pathology
Forensic MedicinePathology
2012English

Effect of Oncotype DX Colon Cancer Test Results on Treatment Recommendations in Patients With Stage II Colon Cancer: Preliminary Results.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy